Saturday, July 11, 2026

pharma · Hypovolemia · Pruritus, Chronic Kidney Diseases

Fresenius Kabi Australia

Fresenius Kabi Australia patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Mount Kuring-Gai, AU HQ
150 Employees
TGA registrant Type
Company details
Status
Public
HQ
Mount Kuring-Gai, AU
Employees
150
Programs
5
Drugs
6
Patents
0
Intelligence · Patents

Fresenius Kabi Australia patents

0 pharmaceutical patents indexed for Fresenius Kabi Australia. 0 expire within 24 months.

Fresenius Kabi Australia has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Fresenius Kabi Australia have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Fresenius Kabi Australia patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.